HopeStage
Back to overview

ADHD studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 157-168 of 1,811
Drug study icon
Recruitment unclearEUCTR 2017-001490-16

Lisdexamphetamine treatment of Bulimia Nervosa with and without probable simultaneous Attention Deficit Hyperactivity Disorder (ADHD). A randomized , open, fase II-study with cross-over design.

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Sweden
ADHD, Eating disordersHistorical research record
Countries
Sweden
Sponsor
Stockholms läns landsting
Behavioral study icon
RecruitingNCT06906328

Methylphenidate with or without cognitive training for ADHD and addiction

About this title

MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response

Read the official source — NCT06906328
Official study title

MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response

In Nantes
ADHD, AddictionBehavioural studyAges 18–99
Countries
France
Sponsor
Nantes University Hospital
Drug study icon
CompletedNCT02059642

MG01CI 1400 mg Compared With Placebo for ADHD

What is this study about?

Researchers compared MG01CI (1400 mg) and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Gainesville
ADHDMedication studyAges 18–55
Countries
United States, Israel
Sponsor
Alcobra Ltd.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.